ACOD1 and ischemic stroke: Thus, our study reveals a novel function of IRG1 in modulating brain injury following ischaemic stroke, and that suggests targeting IRG1 and/or IRG1-mediated signalling pathways may represent a novel therapeutic strategy for the treatment of ischaemic stroke.